Letybo and Xeomin are both botulinum toxin type A, and both use the same 20-unit dose for frown lines.
The difference that actually matters is what each is approved to treat. Xeomin is approved in the US for frown lines, horizontal forehead lines, and crow's feet. Letybo is approved for frown lines only. If you want the upper third of your face treated by the label rather than off it, that is the whole comparison.
Their make-up differs too. Xeomin is a bare toxin with the helper proteins stripped away. Letybo comes as a full protein complex, like most brands.
Made by Hugel. US approval in 2024, launched here in 2025.
Made by Merz. On the US market since 2010.
No medical approvals in the US.
The forehead and crow's feet approvals were added in July 2024.
Approved only when the frown lines are treated at the same time.
The helper proteins are removed during manufacturing.
Approved on three placebo-controlled trials in about 1,270 people.
Also approved for medical conditions including cervical dystonia and excessive drooling.
Most people asking about the forehead are surprised to learn that treating it with botulinum toxin is off-label for nearly every brand. That is normal, legal, and extremely common — but it means the FDA never reviewed the dose or the safety data for that area for those products.
There are two exceptions. Botox Cosmetic has been approved for crow's feet since 2013 and for forehead lines since 2017. Xeomin joined it in July 2024, approved for horizontal forehead lines at 20 units and crow's feet at 24 units alongside the frown lines. Letybo has no such approval, and neither do Dysport, Jeuveau or Daxxify.
If you are treating frown lines only, this does not affect you. If you want your whole upper face treated, it is the single clearest difference between these two products.
Xeomin has no helper proteins around the toxin. The argument runs that fewer foreign proteins means less for the immune system to react to, so people who have stopped responding to another brand may do better on it.
It is a plausible argument and injectors use it. It is not a proven one. If a toxin has stopped working for you, it is worth raising with your injector — but treat it as a reasonable thing to try, not as a guaranteed fix.
One thing worth knowing: Xeomin is not the only product without helper proteins. Daxxify is also a bare toxin, so if this argument holds, it applies to both.
Go to an emergency department or call 911. Do not wait for a call back. These are rare, but they are the symptoms named in the FDA boxed warning that every botulinum toxin product carries, deaths have been reported, and they can begin hours or even weeks after treatment.
If a vision change is sudden or severe, seek urgent care rather than waiting.